Abstract
Background: Schizophrenia is a complex psychiatric disorder that represents a challenge for all clinicians. Although treatment must address both positive and negative symptoms, several authors have reported the importance of managing unmet needs among patients with schizophrenia. Unmet needs in schizophrenia include difficulties at various clinical, psychosocial, relational, economic, and occupational levels. An important unmet need is represented by insight into the illness that is associated with treatment adherence and compliance with medical prescriptions.
Conclusion: In order to improve our understanding and management of schizophrenia, it is critically important to address the complexity of needs among patients with schizophrenia.
Keywords: Cognitive, emotional, psychosocial, psychiatric disorder, symptoms, schizophrenia.
CNS & Neurological Disorders - Drug Targets
Title:Unmet Needs in Schizophrenia
Volume: 16 Issue: 8
Author(s): Maurizio Pompili*, Gloria Giordano, Mario Luciano, Dorian A. Lamis, Valeria Del Vecchio, Gianluca Serafini, Gaia Sampogna, Denise Erbuto, Peter Falkai and Andrea Fiorillo
Affiliation:
- Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Rome,Italy
Keywords: Cognitive, emotional, psychosocial, psychiatric disorder, symptoms, schizophrenia.
Abstract: Background: Schizophrenia is a complex psychiatric disorder that represents a challenge for all clinicians. Although treatment must address both positive and negative symptoms, several authors have reported the importance of managing unmet needs among patients with schizophrenia. Unmet needs in schizophrenia include difficulties at various clinical, psychosocial, relational, economic, and occupational levels. An important unmet need is represented by insight into the illness that is associated with treatment adherence and compliance with medical prescriptions.
Conclusion: In order to improve our understanding and management of schizophrenia, it is critically important to address the complexity of needs among patients with schizophrenia.
Export Options
About this article
Cite this article as:
Pompili Maurizio*, Giordano Gloria , Luciano Mario , Lamis A. Dorian, Del Vecchio Valeria , Serafini Gianluca , Sampogna Gaia , Erbuto Denise , Falkai Peter and Fiorillo Andrea , Unmet Needs in Schizophrenia, CNS & Neurological Disorders - Drug Targets 2017; 16 (8) . https://dx.doi.org/10.2174/1871527316666170803143927
DOI https://dx.doi.org/10.2174/1871527316666170803143927 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Safety of Inactivated Vaccines in Pregnancy
Current Women`s Health Reviews Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
Current Neuropharmacology The Combination of Pill Count and Self-Reported Adherence is a Strong Predictor of First-Line ART Failure for Adults in South Africa
Current HIV Research New Perspectives in the Management of Secondary Hyperparathyroidism
Mini-Reviews in Medicinal Chemistry Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design Predictive In Silico Studies of Human 5-hydroxytryptamine Receptor Subtype 2B (5-HT2B) and Valvular Heart Disease
Current Topics in Medicinal Chemistry Adenoviral Gene Delivery for HIV-1 Vaccination
Current Gene Therapy Clinical Thiazolidinediones as PPARγ Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes
Current Diabetes Reviews The Attentional Set-Shifting Test Paradigm in Rats for the Screening of Novel Pro-Cognitive Compounds with Relevance for Cognitive Deficits in Schizophrenia
Current Pharmaceutical Design Insights in microRNAs Biology
Current Topics in Medicinal Chemistry Nanomedical Strategies for Targeting Skin Microbiomes
Current Drug Metabolism Cardiovascular disease management through restrained inflammatory responses
Current Pharmaceutical Design Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics Novel Superactive Leptin Antagonists and their Potential Therapeutic Applications
Current Pharmaceutical Design Combining “Omics” Strategies to Analyze the Biotechnological Potential of Complex Microbial Environments
Current Protein & Peptide Science Mucoadhesive Chitosan Derivatives as Novel Drug Carriers
Current Pharmaceutical Design An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Therapeutic Value of Statins for Vascular Remodeling
Current Vascular Pharmacology